A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Isolation of Functional Cardiac Immune Cells

14.9K views

⸱

DOI:

10.3791/3020

⸱

December 5th, 2011

 ,  ,  ,  ,  , 

In This Article

Summary

This method for isolating functional immune cells from the heart provides an alternative to the conventional methods of collagenase digestion, which causes unwanted immune cell activation, resulting in a decreased responsiveness of these cells. Our method of isolation yields functional cardiac immune cells by avoiding problems associated with enzymatic digestion.

Abstract

Cardiac immune cells are gaining interest for the roles they play in the pathological remodeling in many cardiac diseases.1-5 These immune cells, which include mast cells, T-cells and macrophages; store and release a variety of biologically active mediators including cytokines and proteases such as tryptase.6-8 These mediators have been shown to be key players in extracellular matrix metabolism by activating matrix metalloproteinases or causing collagen accumulation by modulating the cardiac fibroblasts' function.9-11 However, available techniques for isolating cardiac immune cells have been problematic because they use bacterial collagenase to digest the myocardial tissue. This technique causes activation of the immune cells and thus a loss of function. For example, cardiac mast cells become significantly less responsive to compounds that cause degranulation.12 Therefore, we developed a technique that allows for the isolation of functional cardiac immune cells which would lead to a better understanding of the role of these cells in cardiac disease.13, 14

This method requires a familiarity with the anatomical location of the rat's xiphoid process, axilla and falciform ligament, and pericardium of the heart. These landmarks are important to increase success of the procedure and to ensure a higher yield of cardiac immune cells. These isolated cardiac immune cells can then be used for characterization of functionality, phenotype, maturity, and co-culture experiments with other cardiac cells to gain a better understanding of their interactions.

Protocol

1. Preparation of Hanks' Balance Salt Solution (HBSS)

  1. Autoclave 1 L glass beaker, 1000 mL graduated cylinder, and stir bar.
  2. Reconstitute the HBSS powder solution in the autoclaved 1 L glass beaker to the 900 mL mark with double distilled water.
  3. Mix HBSS solution with 3.4 g of Hepes Na+ salt and adjust the pH to a value between 7.35-7.41 using either concentrated HCL or NaOH.
  4. Once the desired pH has been attained and remains stable, add 5 g of bovine serum albumin to the solution at room temperature until the albumin is completely dissolved.
  5. Add 10 mL of the antibiotic, antimyotic, to the solution and double distilled....

Access restricted. Please log in or start a trial to view this content.

Discussion

This method of isolating cardiac immune cells enables the analysis of their function, phenotype, and maturity without the unwanted activation that typically occurs during a traditional enzymatic digestion isolation technique. The average total number of cells obtained with this technique is around 400,000 per rat heart, and differential staining and flow cytometry analysis of these cells indicates mixed population of T-lymphocytes (~70%), macrophages (~12%) and mast cells with the use of this technique.(~12 %).13, 1.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

We have nothing to disclose.

Acknowledgements

This work was supported by a UNCF-Merck Graduate Science Research Dissertation Fellowship (J.L.M.), National Heart, Lung, and Blood Institute grants RO1-HL-62228 (J.S.J.) and RO1-HL-073990 (J.S.J.).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Hanks’ Balanced SaltSigma-AldrichH4891One bottle makes 1 L of Hanks’ Balance Salt
Solution. Reconstitute Hanks’ Balance Salt
Solution as a part of the procedure.
Antibiotic- AntimyoticGIBCO, by Life Technologies15240-062
HEPESSigma-AldrichH3784
Bovine Serum AlbuminSigma-AldrichA3912
250 mL Nalogene Filter BottleThermo Fisher Scientific, Inc.157-0020
12 N HCLFisher ScientificCAS 7647-01-0For 6 N, add equal volumes of HCL to deionized water.
10 N NaOHFisher ScientificSC267For 5 N, add equal volumes of NaOH to deionized water.
Double Distilled Water
Table of Specific Equipment:
3-O Suture Silk BraidedEthicon Inc.SA64H
Small Animal VentilatorCWE, Inc.SAR-830Set breathing rate to 40.5 breaths per min.
Bevel 18 gauge needleBD Biosciences305199Trim needle by 1/2 to 3/4 of its original length for use as a tracheal tube.
Teflon Tip (with needle removed) of 24-gauge Baxter quick-cath catheterBaxter Internationl Inc.2N111Reduce the Teflon Tip length by 1/2 to 3/4.
10 cc syringeFisher Scientific14-823-16B
15 mL Falcon TubesBD Biosciences352097
Sorvall RT6000B Refrigerated CentrifugeFisher Scientific75-004-377Remember to pre-cool and keep at 4°C.
HycloneThermo Fisher Scientific, Inc.S300030.02
HemocytometerHausser ScientificHS-LB-1483

References

  1. Brower, G. L., Chancey, A. L., Thanigaraj, S., Matsubara, B. B., Janicki, J. S. Cause and effect relationship between myocardial mast cell number and matrix metalloproteinase activity. Am. J. Physiol. Heart. Circ. Physiol. 283, H518-H525 (2002).
  2. Brower, G. L., Janicki, J. S.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Pericardial SpaceHBSS InjectionFlow CytometryImmunofluorescent AnalysisCo-culture ExperimentsChemical DegranulationPericardial PunctureCell IsolationFunctional Analysis